
These photos show the hair loss and wrinkled skin after two months of doxycycline induction, and the same mouse a month later after doxycycline was stopped, allowing restoration of the depleted mitochondrial DNA.
Wrinkled skin and hair loss are hallmarks of aging. What if they could be reversed?
Keshav Singh, Ph.D., and colleagues have done just that, in a mouse model developed at the University of Alabama at Birmingham. When a mutation leading to mitochondrial dysfunction is induced, the mouse develops wrinkled skin and extensive, visible hair loss in a matter of weeks. When the mitochondrial function is restored by turning off the gene responsible for mitochondrial dysfunction, the mouse returns to smooth skin and thick fur, indistinguishable from a healthy mouse of the same age.
“To our knowledge, this observation is unprecedented,” said Singh, a professor of genetics in the UAB School of Medicine.
Importantly, the mutation that does this is in a nuclear gene affecting mitochondrial function, the tiny organelles known as the powerhouses of the cells. Numerous mitochondria in cells produce 90 percent of the chemical energy cells need to survive.
In humans, a decline in mitochondrial function is seen during aging, and mitochondrial dysfunction can drive age-related diseases. A depletion of the DNA in mitochondria is also implicated in human mitochondrial diseases, cardiovascular disease, diabetes, age-associated neurological disorders and cancer.
“This mouse model,” Singh said, “should provide an unprecedented opportunity for the development of preventive and therapeutic drug development strategies to augment the mitochondrial functions for the treatment of aging-associated skin and hair pathology and other human diseases in which mitochondrial dysfunction plays a significant role.”
The mutation in the mouse model is induced when the antibiotic doxycycline is added to the food or drinking water. This causes depletion of mitochondrial DNA because the enzyme to replicate the DNA becomes inactive.
In four weeks, the mice showed gray hair, reduced hair density, hair loss, slowed movements and lethargy, changes that are reminiscent of natural aging. Wrinkled skin was seen four to eight weeks after induction of the mutation, and females had more severe skin wrinkles than males.
Dramatically, this hair loss and wrinkled skin could be reversed by turning off the mutation. The photos below show the hair loss and wrinkled skin after two months of doxycycline induction, and the same mouse a month later after doxycycline was stopped, allowing restoration of the depleted mitochondrial DNA.
Little change was seen in other organs when the mutation was induced, suggesting an important role for mitochondria in skin compared to other tissues.
Among the details, the skin of induced-mutation mice showed increased numbers of skin cells, abnormal thickening of the outer layer, dysfunctional hair follicles and increased inflammation that appeared to contribute to skin pathology. These are similar to extrinsic aging of the skin in humans. The mice with depleted mitochondrial DNA also showed changed expression of four aging-associated markers in cells, similar to intrinsic aging.
The skin also showed disruption in the balance between matrix metalloproteinase enzymes and their tissue-specific inhibitor — a balance of these two is necessary to maintain the collagen fibers in the skin that prevent wrinkling.
The mitochondria of induced-mutation mice had reduced mitochondrial DNA content, altered mitochondrial gene expression, and instability of the large complexes in mitochondria that are involved in oxidative phosphorylation.
Reversal of the mutation restored mitochondrial function, as well as the skin and hair pathology. This showed that mitochondria are reversible regulators of skin aging and loss of hair, an observation that Singh calls “surprising.”
“It suggests that epigenetic mechanisms underlying mitochondria-to-nucleus cross-talk must play an important role in the restoration of normal skin and hair phenotype,” Singh said, who has a secondary UAB appointment as professor of pathology. “Further experiments are required to determine whether phenotypic changes in other organs can also be reversed to wildtype level by restoration of mitrochondrial DNA.”
Learn more: Scientists reverse aging-associated skin wrinkles and hair loss in a mouse model
The Latest on: Mitochondrial function
[google_news title=”” keyword=”mitochondrial function” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Mitochondrial function
- Study points to coding DNA variants as cause for childhood onset schizophreniaon March 30, 2023 at 2:17 am
Israeli research finds that some children with this rare mental illness carry genetic mutations previously found in people with language, learning, and developmental challenges ...
- Advancements and challenges of constructing artificial mitochondria and chloroplastson March 28, 2023 at 8:25 pm
Energy production in nature is the responsibility of chloroplasts and mitochondria and is crucial for fabricating sustainable, synthetic cells in the lab.
- Study elucidates at cellular level how regular exercise preserves physical fitness during agingon March 28, 2023 at 5:00 pm
In sum, we confirmed that exercise and mitochondrial dynamics are significantly associated with the maintenance of muscle function in senescence. This was the proof of concept we were looking for,” ...
- Cyclerion’s Mitochondrial Diseases Candidate Gets Orphan Drug Nodon March 27, 2023 at 5:00 pm
A 29-day study showed the drug candidate was associated with improvements in several disease-relevant biomarkers.
- Exploring a massive supercomplex in mitochondria comprising all four respiratory complexeson March 27, 2023 at 7:58 am
Eukaryotes generate the energy for survival through cellular respiration in mitochondria by a process known as the oxidative phosphorylation. In this process, nutrients and oxygen are converted into a ...
- Cyclerion Gets FDA Orphan Drug Designation For Zagociguat For Mitochondrial Diseaseson March 27, 2023 at 6:48 am
Biopharmaceutical company Cyclerion Therapeutics, Inc. (CYCN) announced that the U.S. Food and Drug Administration (FDA) has granted ...
- Cyclerion Therapeutics Receives U.S. FDA Orphan Drug Designation for Zagociguat for the Treatment of Mitochondrial Diseaseson March 27, 2023 at 3:59 am
CAMBRIDGE, Mass., March 27, 2023 (GLOBE NEWSWIRE) -- (Nasdaq: CYCN), a clinical-stage biopharmaceutical company on a mission to develop treatments for serious diseases, today announced that the U.S.
- A readily available dietary supplement may reverse organ damage caused by HIV and antiretroviral therapyon March 24, 2023 at 6:53 am
MitoQ, a mitochondrial antioxidant that is available to the public as a diet supplement, was found in a mouse study to reverse the detrimental effects that HIV and antiretroviral therapy (ART) have on ...
- New intracellular 'smoke detector' discoveredon March 21, 2023 at 7:51 pm
Researchers have discovered a new intracellular 'smoke detector.' The sensor warns of damage to the mitochondria -- the microscopic power plants that supply the cell with energy. If it does not ...
via Bing News